November 20, 2026

Britain approves Pfizer/BioNTech's updated COVID-19 booster vaccine

The booster shot with the bivalent Pfizer/BioNTech vaccine triggers a strong immune response against both the omicron and the original strain, data shows

Britain approves Pfizer/BioNTech's updated COVID-19 booster vaccine
A vial and syringe are seen in front of a displayed Pfizer and BioNTech logo in this illustration taken Jan 11, 2021. REUTERS

Reuters

Published : 03 Sep 2022, 06:01 PM

Updated : 03 Sep 2022, 06:01 PM

Britain's medicines regulator on Saturday approved Pfizer/BioNTech's updated bivalent COVID-19 booster shot for people aged 12 years and older.

The Medicines and Healthcare products Regulatory Agency said the decision was based on data from a clinical trial that showed a booster dose with the bivalent Pfizer/BioNTech vaccine triggers a strong immune response against both the omicron and the original strain.

Also Read:

CDC data suggests boosters’ protection against severe COVID-19 plunges after 4 months

Also Read:

Singapore approves COVID-19 vaccine boosters for age 12-17s

Also Read:

WHO says no evidence healthy children, adolescents need COVID-19 boosters

Also Read:

Pfizer study shows COVID-19 booster can be given along with pneumonia shot
Related Stories